BeStock  
Stocks › Medical Devices › CTKB

Cytek Biosciences CTKB

US equityMarket cap rank #3306Medical Devices
$6.12 −$0.20 (-3.16%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $6.12 0.00%
Open$6.31
Prev close$6.32
Day range$5.99 – $6.39
Volume1.77M
Market cap$800.40M
P/E (TTM)–
Dividend yield–

Fundamentals

Latest reported quarter: Q3, ended Sep 2026

Revenue$53.23M+1.8% YoY
Operating profit-$8.42M+8.4% YoY
Net profit-$6.10M-11.3% YoY
Diluted EPS-$0.05-25.0% YoY
Free cash flow-$6.00M-31.8% YoY
Operating cash flow-$4.45M

Revenue, last 8 quarters

$57.5MDec '24$41.5MMar '25$45.6MJun '25$52.3MSep '25$62.1MDec '25$44.1MMar '26$48.1MJun '26$53.2MSep '26

Net profit, last 8 quarters

$9.6MDec '24$-11.4MMar '25$-5.6MJun '25$-5.5MSep '25$-44.1MDec '25$-18.9MMar '26$-12.2MJun '26$-6.1MSep '26

Diluted EPS by quarter

0.07Dec '24-0.09Mar '25-0.04Jun '25-0.04Sep '25-0.34Dec '25-0.15Mar '26-0.09Jun '26-0.05Sep '26

Free cash flow by quarter

$1.1MDec '24$-976.0KMar '25$-1.5MJun '25$-4.6MSep '25$-1.8MDec '25$-4.9MMar '26$-877.0KJun '26$-6.0MSep '26

Annual revenue

$92.8MFY20$128.0MFY21$164.0MFY22$193.0MFY23$200.5MFY24$201.5MFY25

Profitability & balance sheet

Gross margin54.7%
Operating margin-21.1%
Net margin-39.1%
Return on equity-23.2%
Return on assets-17.3%
Return on invested capital-22.2%
Current ratio4.46
Liabilities / assets28.0%
Cash & investments$255.90M
Total debt$21.23M
Net cash (debt)$234.67M

Where the revenue comes from

Quarter 2026/Q3

By business line

  • Product$37.16M 69.8%
  • Service$16.07M 30.2%

Income statement

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Revenue as Reported $53.23M $48.14M $44.14M $201.49M $62.14M
Total Operating Revenue $53.23M $48.14M $44.14M $201.49M $62.14M
Cost of Revenue $22.02M $19.80M $22.88M $97.03M $29.26M
Gross Profit $31.21M $28.34M $21.25M $104.46M $32.89M
Operating Expense $39.63M $39.74M $39.72M $144.84M $38.48M
Selling and Admin Expenses $30.27M $30.00M $30.11M $108.38M $29.52M
-Selling & Marketing Expense $11.91M $13.17M $11.65M $49.44M $13.13M
-General & Admin Expense $18.36M $16.83M $18.47M $58.94M $16.39M
Research & Development $9.36M $9.74M $9.60M $36.47M $8.96M
Operating Profit -$8.42M -$11.40M -$18.46M -$40.38M -$5.59M
Net Non-Operating Interest Income (Expense) $764,000.00 $538,000.00 $525,000.00 $1.74M $1.31M
Non-Operating Interest Income $1.02M $819,000.00 $787,000.00 $2.22M $580,000.00
Non-Operating Interest Expense $260,000.00 $281,000.00 $262,000.00 $474,000.00 -$725,000.00
Other Income (Expense) $751,000.00 -$781,000.00 $565,000.00 $8.80M $258,000.00
Other Non-Operating Income (Expenses) $751,000.00 -$781,000.00 $565,000.00 $8.80M $258,000.00
Pretax Profit -$6.91M -$11.64M -$17.37M -$29.84M -$4.03M
Tax -$811,000.00 $515,000.00 $1.49M $36.70M $40.05M
Net Profit -$6.10M -$12.16M -$18.87M -$66.54M -$44.08M
Profit from Continuing Operations -$6.10M -$12.16M -$18.87M -$66.54M -$44.08M
Net Income to Parent Company -$6.10M -$12.16M -$18.87M -$66.54M -$44.08M
Net Income to Common Stockholders -$6.10M -$12.16M -$18.87M -$66.54M -$44.08M
Basic EPS -$0.05 -$0.09 -$0.15 -$0.52 -$0.34
Diluted EPS -$0.05 -$0.09 -$0.15 -$0.52 -$0.34
Minority Interests – – – $0.00 –

Balance sheet

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Assets $446.15M $446.93M $449.11M $461.54M $461.54M
Total Current Assets $378.94M $377.93M $379.30M $392.00M $392.00M
Cash and Cash Equivalents & Short-Term Investments $255.90M $262.00M $262.23M $261.53M $261.53M
-Cash and Cash Equivalents $66.81M $73.85M $65.67M $90.85M $90.85M
-Short Term Investments $189.09M $188.16M $196.56M $170.68M $170.68M
Receivables $60.78M $51.30M $56.48M $72.13M $72.13M
-Accounts Receivable $59.19M $49.70M $51.90M $62.51M $62.51M
-Taxes Receivable $1.01M $1.02M $1.02M $5.41M $5.41M
-Other Receivables $575,000.00 $582,000.00 $3.56M $4.21M $4.21M
Prepaid Assets $6.81M $6.90M $7.21M $6.94M $6.94M
Inventory $52.37M $52.25M $49.79M $48.43M $48.43M
Restricted Cash $385,000.00 – – $0.00 $0.00
Other Current Assets $2.69M $5.48M $3.60M $2.98M $2.98M
Total Non-Current Assets $67.21M $69.00M $69.81M $69.55M $69.55M
Net PPE $30.94M $31.76M $31.11M $29.32M $29.32M
-Gross PPE $46.31M $45.99M $44.17M $41.46M $41.46M
-Accumulated Depreciation -$15.37M -$14.22M -$13.06M -$12.13M -$12.13M
Goodwill and Other Intangible Assets $30.72M $31.56M $32.39M $33.52M $33.52M
-Goodwill $16.69M $16.69M $16.69M $16.70M $16.70M
-Other Intangible Assets $14.03M $14.87M $15.70M $16.82M $16.82M
Other Non-Current Assets $5.55M $5.69M $6.31M $6.70M $6.70M
Total Liabilities $124.79M $124.98M $121.47M $119.80M $119.80M
Total Current Liabilities $84.95M $84.34M $80.94M $77.80M $77.80M
Payables $11.13M $14.76M $13.77M $12.69M $12.69M
-Accounts Payable $4.89M $8.41M $6.74M $6.41M $6.41M
-Total Tax Payable $6.25M $6.35M $7.03M $6.28M $6.28M
Current Accrued Expenses $13.90M $11.75M $11.71M $8.23M $8.23M
Short-Term Debt and Capital Lease Obligation $11.81M $12.70M $13.66M $9.18M $9.18M
-Current Debt $8.35M $9.43M $10.71M $6.30M $6.30M
-Current Capital Lease Obligation $3.46M $3.27M $2.94M $2.88M $2.88M
Current Deferred Liabilities $32.07M $30.32M $31.18M $29.57M $29.57M
Other Current Liabilities $2.79M $2.70M $2.55M $2.95M $2.95M
Total Non-Current Liabilities $39.84M $40.65M $40.53M $42.00M $42.00M
Long Term Debt and Capital Lease Obligation $12.88M $13.76M $13.83M $14.57M $14.57M
-Long Term Debt $99,000.00 $246,000.00 $386,000.00 $525,000.00 $525,000.00
-Long Term Capital Lease Obligation $12.78M $13.52M $13.44M $14.04M $14.04M
Non-Current Deferred Liabilities $18.74M $18.06M $17.67M $18.34M $18.34M
Other Non-Current Liabilities $8.22M $8.82M $9.04M $9.09M $9.09M
Total Equity $321.35M $321.95M $327.64M $341.74M $341.74M
Stockholders' Equity $321.35M $321.95M $327.64M $341.74M $341.74M
Capital Stock $131,000.00 $130,000.00 $129,000.00 $129,000.00 $129,000.00
-Common Stock $131,000.00 $130,000.00 $129,000.00 $129,000.00 $129,000.00
Additional Paid-In Capital $457.44M $451.85M $445.75M $441.11M $441.11M
Retained Earnings -$138.86M -$132.76M -$120.60M -$101.74M -$101.74M
Gains/Losses Not Affecting Retained Earnings $2.64M $2.74M $2.37M $2.24M $2.24M
Non-Current Deferred Assets – – – $0.00 $0.00
Minority Interests – – – $0.00 $0.00

Cash flow

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Operating Cash Flow -$4.45M $1.37M -$2.74M -$4.69M -$771,000.00
Net cash flow from continuing operations -$4.45M $1.37M -$2.74M -$4.69M -$771,000.00
Net Income from Continuing Operations -$6.10M -$12.16M -$18.87M -$66.54M -$44.08M
Gain/Loss from Continuing Operations -$830,000.00 -$1.16M -$1.20M -$5.26M -$1.15M
Depreciation & Depletion & Amortization $3.11M $2.99M $2.81M $11.98M $3.04M
Deferred Tax $0.00 $0.00 -$183,000.00 $33.56M $38.58M
Other Non-Cash Items -$134,000.00 $1.68M $189,000.00 -$328,000.00 -$761,000.00
Change in Working Capital -$5.89M $4.19M $9.00M -$4.79M -$3.48M
-Change in Receivables -$10.08M $1.97M $9.65M $368,000.00 -$6.15M
-Change in Inventory -$222,000.00 -$2.86M -$1.63M -$5.24M $2.05M
-Change in Prepaid Assets $3.14M -$2.25M $3.85M -$2.66M -$3.35M
-Change in Payables and Accrued Expense $698,000.00 $5.86M -$3.50M $4.42M $3.40M
-Change in Other Current Liabilities -$1.17M $1.87M -$548,000.00 -$5.28M -$1.16M
-Change In Other Working Capital $1.75M -$400,000.00 $1.18M $3.60M $1.74M
Net cash flow from investing -$1.80M $7.02M -$27.08M $10.12M -$1.84M
Net Cash Flow from Continuing Investing Activities -$1.80M $7.02M -$27.08M $10.12M -$1.84M
Net PPE Purchase and Sale -$1.44M -$2.21M -$2.16M -$3.83M -$806,000.00
Net Intangibles Purchase and Sale -$42,000.00 -$28,000.00 -$33,000.00 -$106,000.00 -$32,000.00
Net Investment Purchase and Sale -$323,000.00 $9.26M -$24.88M $14.06M -$1.00M
Financing Cash Flow -$561,000.00 -$814,000.00 $3.98M -$13.43M -$1.23M
Net Cash Flow from Continuing Financing Activities -$561,000.00 -$814,000.00 $3.98M -$13.43M -$1.23M
Net Issuance Payments Of Debt -$1.31M -$1.57M $4.20M $837,000.00 -$1.52M
Net Common Stock Issuance $0.00 $0.00 $0.00 -$15.07M $34,000.00
Proceeds from Stock Option Exercised $1.01M $942,000.00 $21,000.00 $1.47M $531,000.00
Net Other Financing Charges -$264,000.00 -$184,000.00 -$239,000.00 -$669,000.00 -$267,000.00
Ending Cash Balance $67.19M $73.85M $65.67M $90.85M $90.85M
Net Change in Cash -$6.81M $7.58M -$25.83M -$8.00M -$3.84M
Beginning Cash Balance $73.85M $65.67M $90.85M $98.75M $93.28M
Effect of Exchange Rate Changes $158,000.00 $606,000.00 $646,000.00 $109,000.00 $1.41M
Free Cash Flow -$6.00M -$877,000.00 -$4.94M -$8.88M -$1.80M
Net Business Purchase and Sale – – – $0.00 –
Net Other Investing Changes – – – -$1,000.00 –

Discussion

No comments yet — be the first to weigh in on CTKB.

Sign in to join the discussion.

Scroll to Top